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Research article  
HPTLC assay of nicotine and cotinine in 
biological samples   
 Ana Maria Vlasceanu1, Daniela Luiza Baconi1, Anne Marie Ciobanu1, Vlad D. 
Constantin2, Liana Pleș2, Cristian Balalau2, Miriana Stan1 
   
1Carol Davila University of Medicine and Pharmacy, Faculty of Pharmacy, Bucharest, Romania 
2Carol Davila University of Medicine and Pharmacy, Faculty of General Medicine, Bucharest, Romania 
   
Abstract This study presents the development of a simple high-performance thin layer chromatography 
(HPTLC) method for the determination of nicotine and its metabolite cotinine in human plasma 
and urine. 
The following mobile phases: methanol: ammonia (100:1.5, v:v), chloroform: acetone: 
ammonia (48.75: 48.75: 2.5, v:v:v), methanol: chloroform: ammonia (48.75: 48.75: 0.5, v:v:v) 
and glass plates precoated with silicagel 60 F254 (20x20) as a stationary phase were used. 
Densitometric scanning was performed at 263 nm. Two different extraction procedures have been 
applied: liquid-liquid extraction using dichloromethane at alkaline pH and solid-phase extraction 
using C18 cartridges. 
Preliminary tests in order to establish the system of solvents for development, as well as the 
range of linearity, were conducted. The best separation of nicotine and cotinine was obtained by 
using methanol: chloroform: ammonia (48.75: 48.75: 0.5, v:v:v) as the mobile phase. The liquid-
liquid extraction technique led to better results than solid phase extraction. The regression curves 
were linear (with a corresponding correlation coefficient higher than 0.99) in the quantities range 
of 200 ng–1000 ng/spot for both nicotine and cotinine. The UV spectra confirm the identification 
of nicotine and cotinine both in the standards and in the extracts after liquid-liquid extraction. 
The proposed method can be applied for the simultaneous evaluation of nicotine and cotinine 
in biological samples at toxic/lethal levels. Thus, the method may be applicable in lethal nicotine 
intoxication cases in forensic toxicological analysis.    
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Highlights ✓ Experimental conditions for identification (through HPTLC) of nicotine and cotinine in 
plasma and urine are presented. 
✓ The method allows the semi-quantitative evaluation of nicotine and cotinine in the range 
of quantities 200 – 1000 ng/spot, the calibration curves being linear.  
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Introduction 
According to the recent literature, acute poisonings, 
mainly in infants and children, caused by nicotine 
products used as substitutes in the treatment of smoking 
(such as chewable gums, transdermal nicotine patch 
etc.) or other tobacco products, are commonly reported 
to poison control centers (1-3).  
The vast majority (90%) of these accidental 
intoxications involve children up to 6 years of age (4, 5). 
In the US, most such intoxications are reported with 
products that looks similar to Tic-Tac candy and contain 
appetizing flavors for young children. A total of 13,705 
cases of ingestion of cigarettes and nicotine products 
were reported in 2010, of which 70% involved children 
under 1 year of age (6, 7). 
Cotinine is the main metabolite of nicotine, having 
a long half-life of elimination, and which can be 
determined in various biological fluids for up to a few 
days after exposure to tobacco smoke (8). Cotinine from 
serum, saliva, or urine has now been recognized as a 
specific, highly sensitive, and reliable general biomarker 
for human exposure to tobacco smoke or substitution 
products containing nicotine (gummy gums, 
transdermal patches, etc.) (9, 10). 
Considering the research literature on nicotine 
poisoning, we conducted a study by HPTLC on the 
identification and semi-quantitative determination of 
nicotine and cotinine from biological material (plasma 
and urine). In this study we evaluated the possibility of 
applying the methods developed in cases of acute 
nicotine intoxication. 
Materials and Methods 
Reactives: (-) Nicotine standard (Merck) min.99%, 
(S) (-) Cotinine standard (Sigma-Aldrich) min. 98%, 
Methanol Chromosolv for HPLC (Merck), Chloroform, 
Acetone, Dicloromethane, Ammonia (analytical grade). 
Apparatus: Cooling centrifuge 2-15 K (Sigma), 
solid phase extraction system (Visiprep Manifold 
model, Supelco), evaporator under nitrogen stream 
(Techne Dry-Block DB-3D model, Bibby Scientífic 
Inc.), Hamilton 100 µL micro-syringe, chromatographic 
development chambers, Camag Linomat 5 semi-
automated spotting system, Camag TLC Scanner 3 
system of processing the chromatoplates, fitted with a 
dark camera, UV lamps and connected to a computer 
(WinCATS software ver. 1.4.4.) 
Biologic material used for the preparation of the 
spiked samples: human plasma obtained from peripheral 
venous blood and urine (from healthy volunteers). 
Methodology 
Preparation of the solution. 
We prepared standard stock solutions of 0.1% 
nicotine and 0.15% cotinine, in methanol.  
Procedures of extractions from plasma and urine 
Liquid-liquid extraction: the spiked sample (1 mL) 
has been alkalized with KOH 1M, then extracted by 
vortex agitation with 5 mL of dichloromethane. After 
extraction, the samples were centrifuged at 4000 rpm, 
24°C, for ten minutes; the organic solvent layer was 
separated and dry-evaporated, in nitrogen flow, at 40°C. 
The residue was taken with 1 mL methanol.  
Solid phase extraction: the spiked sample (1 mL) 
was alkalized with KOH 1M. The cartridge was washed 
with a mixture of methanol / sodium hydroxide solution 
20%, then the sample was slowly passed over the solid 
phase thus conditioned. Subsequently, the analytes were 
eluted with 1 mL of methanol, the solution was dry-
evaporated in nitrogen flow, at 40°C and the residue was 
taken with 0.5 mL methanol.  
Working procedure 
We have planned to spot the solutions to be 
analyzed, containing the order of setting the solutions on 
the plate and the volumes which are to be spotted for 
each migration track (Table 1). 
Table 1. Spotting plan for the semi quantitative 
assay of nicotine and cotinine in urine and plasma. 
Track 
No. 
1-5 6 7-15 
Sample 
Nicotine/ 
Cotinine Blank 
urine/plasma 
Urine/ 
plasma 
extract*  
Volume 
(µL) 
5    10 15  20 25 5 5 15 25 
*triplicate 
According to the plan of obtaining the chromate-
plate, the solutions to be analysed were spotted in lines, 
using the semi-automatic system Linomat 5 (Camag), by 
means of the Hamilton micro syringe, in nitrogen flow. 
The plates were developed in the vertical chamber 
(the technique has been the ascending one), previously 
saturated with the vapours of the mobile phase. 
After the development, the plates were evaluated 
using the TLC scanner 3 (Camag), at 263 nm. 
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Results 
HPTLC analysis of the nicotine and cotinine, after 
being extracted from urine.  
We conducted a series of tests to select the optimal 
developing solvent system and to establish the standard 
curves, using standard solutions, as well as checking the 
extraction from biological material. 
Thus, we performed the standard curve in the 
quantities range of 200 ng - 1000 ng/spot (200 ng - 400 
ng - 600 ng - 800 ng - 1000 ng/spot); the extraction of 
urine samples was performed by the liquid–liquid 
procedure at pH alkaline, using dichloromethane as the 
extraction solvent. We verified the extraction of nicotine 
and cotinine from the urine at three levels of the 
calibration curve: 200 ng/spot, 800 ng/spot and 1000 
ng/spot. We worked in triplicate for each level in the 
calibration curve.  
In the solvent system used as the developer, 
methanol: ammonia (100: 1.5), nicotine and cotinine 
were characterized by Rf values of 0.795 ± 0.00522 and 
0.83 ± 0.0094, respectively, according to the data 
generated in the software report. Therefore, the 
developing system methanol: ammonia (100: 1.5) is not 
suitable for the separation of nicotine and its metabolite 
cotinine. By using the mobile phase chloroform: 
acetone: ammonia (48,75: 48,75: 2,5), the Rf values 
decrease significantly (Rf nicotine = 0.2740 ±0.00522, 
and Rfcotinine = 0.3430 ±0.00421), but no proper 
separation was obtained (Figure 1).  
 
 
Figure 1. The chromatogram obtained at the 
evaluation of nicotine and cotinine in the urine 
using HPTLC [liquid-liquid extraction; a) 3D 
chromatogram; b) Integrated peak for the 
nicotine and cotinine extracted from urine] 
For the quantity range of 200 ng – 1000 ng/spot, the 
calibration curves with a corresponding correlation 
coefficient of over 0.99 were obtained. As seen in the 
regression curves, we have obtained linear regressions 
with correlation coefficients higher than 0.99 in the case 
of using the area, but not the height of the chromatogram 
peak (Table 2). The calibration curves for nicotine and 
cotinine are presented in the Figure 2. 
Table 2. Parameters of the regression curves obtained in 
the semi-quantitative analysis of the nicotine and cotinine 
in urine 
Size taken 
into account 
Equation  
of the 
regression 
line 
Correlation 
coefficient 
(r) 
Average  
standard 
deviation of the 
points towards 
the regression 
line 
Area of the 
peak 
(nicotine) 
Y=2866 
+ 
14.57*X 
0.99488 4.65 %  
Height of 
the peak 
(nicotine) 
Y=128.5 +  
 0.3193*X 
0.97856 7.67 % 
Area of the 
peak 
(cotinine) 
Y=7257+ 
24.67*X 
0.99054 5.66 % 
Height of 
the peak 
(cotinine) 
Y=243.2 
+ 
0.3126*X 
0.95993 7.73 % 
 
Figure 2. The calibration curves for nicotine (a) and 
cotinine (b) in the range of 200 – 1000 ng/mL 
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UV spectra corresponding to the peaks separated at 
Rf values approximately 0.27 and 0.34 confirm the 
presence of the nicotine (Figure 3-a.) and cotinine 
(Figure 3-b.) both in the standard solution and in the 
extracts. 
 
 
Figure 3. The UV spectra of nicotine (a.) and 
cotinine (b.) standard solution and after being 
extracted from the urine corresponding to the 
spots separated by HPTLC 
The accuracy of the method, evaluated as 
percentage of recovery after extraction was determined 
(Table 3), with results indicating an overestimation of 
the percent of recovery, mainly at low quantities. 
Table 3. The accuracy (as percentage of 
recovery after extraction) of HPTLC method 
for the determination of nicotine and cotinine in 
urine 
Quantity (ng/spot) 200 800 1000 
Average recovery 
percentage (%) 
131.91 101.20 110 
Standard deviation 1.21 1.85 1.57 
HPTLC analysis of the nicotine and cotinine, after 
being extracted from plasma 
The best separation of nicotine and cotinine was 
achieved by using a mobile phase consisting of 
methanol: chloroform: ammonia (48.75: 48.75: 0.5). 
The Rf values for nicotine and cotinine were 0.45±0.01 
and 0.34±0.01 respectively (Figure 4). 
 
 
 
 
Figure 4. The chromatogram obtained at the 
evaluation of the nicotine and cotinine in the urine 
using HPTLC (solid-phase extraction; a. 3D 
chromatogram; b. Integrated peak for the nicotine 
and cotinine extracted from plasma) 
We also established the calibration curves using 
five quantity levels of nicotine and cotinine in the range 
of 200 – 1000 ng/mL. The experimental data fit the 
model of linear equations y = A + Bx well, by using only 
the area of the peak as a size of quantification (Table 4). 
Table 4. Parameters of the regression curves 
obtained in the semi-quantitative analysis of the 
nicotine and cotinine in plasma 
Size taken into 
account 
 
The equation  
of the 
regression  
line 
 
Correlation 
coefficient 
(r) 
Average 
standard 
deviation of the 
points towards 
the regression 
line 
Area of the peak 
(nicotine) 
Y=1892.133 
+ 15.61*X 
0.99610 2.46 % 
Area of the peak 
(cotinine) 
Y=3345 + 
14.42*X 
0.99265 5.35% 
In experiments on plasma samples, we applied the 
solid-phase extraction procedure. The results indicate 
that the solid-phase extraction procedure is not suitable 
for the extraction of nicotine and cotinine from the 
plasma (Figure 4-a). 
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Discussions 
This paper aimed to develop a simple, efficient, and 
inexpensive analytical method for evaluating nicotine 
and its metabolite cotinine in biological samples (plasma 
and urine). Thus, the analytical toxicology study on 
nicotine and cotinine proposed in this paper supports 
efforts to improve the methods of analysis for 
substances frequently reported in intoxications, having 
in view that toxicology laboratories require new, faster, 
more sensitive, and less costly methods.  
Thin layer chromatography (TLC) draws the 
attention as a basic analytic method due to its simplicity, 
robustness, low cost, and selectivity of detection, by 
using various procedures of tracking. It is the most 
efficient method for low cost analyses of a large number 
of tests, especially for screening the abuse substances 
present in biological fluids and tissues (11). 
The research conducted herein has taken into 
consideration the fact that over time many methods have 
been developed for the determination of nicotine and its 
cotinine metabolite from biological fluids, but most 
involve either toxic solvents (such as benzene) or 
complex equipment such as HPLC, mass spectrometer, 
etc. The extraction methods reported in the literature 
imply either solid phase extraction on an octadecylsilane 
(C18) cartridge or different liquid-liquid extraction 
techniques (12, 13). Most TLC methods for nicotine 
determination have been developed for evaluation in 
tobacco extracts or tobacco products (14, 15). Generally, 
there are few TLC methods for evaluating nicotine along 
with its metabolite cotinine in biological samples.  
Based on data in the literature regarding the analysis 
of nicotine by TLC, we have done a series of preliminary 
tests in order to establish the system of solvents for 
separating nicotine from its metabolite, as well as the 
range of linearity. As part of these tests, we checked the 
extraction from urine and plasma samples, by testing 
comparatively two extraction methods: a liquid-liquid 
method, using dichloromethane as solvent, and a solid-
phase extraction method using C18 cartridge. These 
experimental explorations, correlated with the 
evaluation of the data reported in the literature, have 
shown that the liquid-liquid extraction is more 
advantageous. Spectra of the nicotine and cotinine peaks 
in standard solutions and urine extracts as well as peak 
purity of extracted substances show that the extraction 
procedure used is appropriate, as the peak is pure. 
However, at very low concentrations, there is a tendency 
to overestimate the yields of extraction. The solid-phase 
extraction method, although shorter regarding analysis 
time, is not appropriate, because neither nicotine nor its 
metabolite could be extracted from plasma (16). 
We have also assessed several systems of solvents 
as a mobile phase (methanol: ammonia 100:1.5; 
chloroform: acetone: ammonia 48.75:48.75:2.5; 
chloroform: methanol: ammonia 48.75:48.75:0.5), on 
the basis of which we have selected the system 
chloroform: methanol: ammonia 48.75:48.75:0.5, as the 
best for the separation of the nicotine from cotinine. By 
using the first solvent system (methanol: ammonia 
100:1.5), the Rf values are high (around of 0.80) and the 
nicotine does not separate from cotinine. The reduction 
of the solvent polarity with the second solvent system 
chloroform: acetone: ammonia (48.75:48.75:2.5) 
resulted in decreased Rf values (0.27 for nicotine and 
0.34 for cotinine), but good separation was not obtained. 
Changing the composition of the solvent system by 
replacing acetone with methanol, more polar solvent and 
reducing the amount of alkalizing agent provided the 
best separation of nicotine from cotinine (Rf values of 
0.45 and 0.34, respectively). The Rf values fall within 
the acceptability condition on the deviation of ± 5% (16, 
17, 18). 
WinCATS software carries out the quantitative 
analysis of the chromatograms obtained through TLC. 
This procedure provides calibration graphics which 
represent the height of the peak or its integrated area 
according to the quantity of spotted substance. The 
experimental results indicate that, for the quantity range 
of 200 ng – 1000 ng/spot, the calibration plots with a 
good linear relationship (correlation coefficient over 
0.99) have been obtained both for nicotine and cotinine 
by using the area of the peak as a measure of 
quantification (19). 
Conclusions 
We have established the experimental conditions 
for the identification through HPTLC of the nicotine in 
presence of its main metabolite, cotinine, in samples of 
plasma and urine. Thus, we have done the analysis of the 
nicotine and its metabolite cotinine, using pre-coated 
glass plates (silicagel 60 F 254), the mobile phase 
chloroform: methanol: ammonia 48.75:48.75:0.5, and 
detection at 263 nm. The positive identification has been 
confirmed by the similarity of the UV spectra of the 
extracted substances, with those of the standard 
solutions. 
The method allowed the semi-quantitative 
evaluation of nicotine and cotinine in the range of 
quantities 200 – 1000 ng/spot, the calibration curves 
being linear. 
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 The results indicated that the solid-phase extraction 
of nicotine and cotinine from the plasma was not 
efficient and either optimization of the technique or 
liquid-liquid extraction is required.  
The elaborated method can be used for the 
simultaneous determination of nicotine and cotinine in 
biological samples at high (toxic or lethal) 
concentrations.  
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